Author/Authors :
Abubakar, Hossam Department of Internal Medicine - Wayne State University, Detroit, USA , Rashed, Ahmed Department of Cardiovascular Medicine - DMC Wayne State University, Detroit, USA , Subahi, Ahmed Department of Internal Medicine - Wayne State University, Detroit, USA , Yassin, Ahmed S. Department of Internal Medicine - Wayne State University, Detroit, USA , Shokr, Mohamed Department of Cardiovascular Medicine - DMC Wayne State University, Detroit, USA , Elder, Mahir Department of Cardiovascular Medicine - DMC Wayne State University, Detroit, USA
Abstract :
AngioVac is a vacuum-based device approved in 2014 for percutaneous removal of undesirable materials from the intravascular
system. Although numerous reports exist with regard to the use of the AngioVac device in aspiration of iliocaval, pulmonary,
upper extremity, and right-sided heart chamber thrombi, very few data are present demonstrating its use in treatment of rightsided endocarditis. In this case report, we describe the novel device used in debulking a large right-sided tricuspid valve vegetation
reducing the occurrence of septic embolisation and enhancing the e2cacy of antibiotics in clearance of bloodstream infection.
Further research is needed in larger RSIE patient populations to con5rm the bene5ts and the potential of improved outcomes
associated with the AngioVac device as well as identify its potential complications.
